Global Small
Molecule API Market, by API Type (Artificial, and Natural), by Category
(Analgesic, Anesthetics, Anticonvulsants, Antimetabolites, Antibacterial,
Alkylating Agents, and Others), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 126.6 billion
in 2017, and is projected to exhibit a CAGR of 9.1% over the forecast period
(2018 – 2026).
Strong research and development
in API by market players to augment the market growth Key players in the market
are focused on research and development in order to develop novel products to
address the critical and unmet needs of patients. For instance, according to
India Brand Equity Foundation (IBEF), investment in research and development by
India-based pharmaceutical companies increased (in term of sales) from 5.3% to
8.5% from 2012 to 2018. Similarly, as per U.S. Food and Drug Administration
(FDA), in March 2016, there were around 37 drugs in clinical development for
treating serious bacterial infections. These drugs are intended to be primarily
launched in the U.S. Moreover, increasing prevalence of various types of
cancers worldwide is expected to boost the market growth. International Agency
for Research on Cancer published the GLOBOCAN 2018 report, which focuses on
geographic variability of cancer incidence and mortality rate across 20 world
regions. The report projected 18.1 million new cancer cases (17.0 million
excluding non-melanoma skin cancer) and 9.6 million cancer deaths (9.5 million
excluding non-melanoma skin cancer) in 2018.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2423
Browse 34 Market Data Tables and
23 Figures spread through 261 Pages and in-depth TOC on ‘Small Molecule API
Market’- Global Forecast to 2026, by API Type (Artificial, and Natural), by
Category (Analgesic, Anesthetics, Anticonvulsants, Antimetabolites,
Antibacterial, Alkylating Agents, and Others), and by Region (North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa)
Key players in the market are
focused on adopting strategies such as mergers and acquisitions to enhance
their product portfolio. In October 2017, CordenPharma announced acquisition of
Pfizer Inc., a manufacturing facility of API Hospira in Colorado, U.S. This
acquisition strengthened the CordenParma’s position, as a leading Contract
Development & Manufacturing Organization (CDMO).
Key Takeaways of the Small
Molecule API Market:
The global small molecule API
market is expected to exhibit a CAGR of 9.1% over the forecast period, owing to
increasing prevalence of cancer and other diseases, extensive research and
development for API production and expansion strategies by the market players.
In October 2016, Cambrex Corporation acquired the 35,000-square-foot High Point
site, formerly owned by PharmaCore
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/small-molecule-api-market-2423
Among API type, the artificial
segment held a dominant position in the small molecule API market in 2018,
owing to high prevalence of chronic pain diseases worldwide
Among Category, the analgesic
segment hold a dominant position in the small molecule API market in 2018, as
the majority of recent generics launches are in form of sublingual films used
in treatment of opioid dependence.
Key players operating in the
global small molecule API market include, Siegfried, Sanofi, Johnson Matthey,
Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs,
Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran
Shimi Pharmaceutical Co.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2423
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment